These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28265809)

  • 1. Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine.
    Matsuoka H; Yoshiuchi K; Koyama A; Makimura C; Fujita Y; Tsurutani J; Sakai K; Sakamoto R; Nishio K; Nakagawa K
    Int J Behav Med; 2017 Aug; 24(4):535-541. PubMed ID: 28265809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
    BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery.
    Ahlers SJ; Elens LL; van Gulik L; van Schaik RH; van Dongen EP; Bruins P; Tibboel D; Knibbe CA
    Br J Clin Pharmacol; 2013 Jun; 75(6):1506-15. PubMed ID: 23210659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Sakai K; Yoshida T; Nakura M; Sakamoto R; Makimura C; Ohtake Y; Tanaka K; Hayashi H; Takeda M; Okuno T; Takegawa N; Haratani K; Koyama A; Nishio K; Nakagawa K
    Oncologist; 2023 Mar; 28(3):278-e166. PubMed ID: 36426809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between intensity and relief in patients with acute severe pain.
    Bernstein SL; Bijur PE; Gallagher EJ
    Am J Emerg Med; 2006 Mar; 24(2):162-6. PubMed ID: 16490644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study.
    Lee KH; Kang JH; Oh HS; Choi MK; Shim BY; Eum YJ; Park HJ; Kang JH
    Pain Res Manag; 2017; 2017():9741729. PubMed ID: 29670416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Analgesic Effect of Magnesium and Morphine in Combination in Patients With Cancer Pain: A Comparative Randomized Double-Blind Study.
    Baaklini LG; Arruda GV; Sakata RK
    Am J Hosp Palliat Care; 2017 May; 34(4):353-357. PubMed ID: 26692084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
    Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
    Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.
    Lucenteforte E; Vannacci A; Crescioli G; Lombardi N; Vagnoli L; Giunti L; Cetica V; Coniglio ML; Pugi A; Bonaiuti R; Aricò M; Giglio S; Messeri A; Barale R; Giovannelli L; Mugelli A; Maggini V
    BMC Cancer; 2019 Jan; 19(1):113. PubMed ID: 30704436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
    Cargnin S; Magnani F; Viana M; Tassorelli C; Mittino D; Cantello R; Sances G; Nappi G; Canonico PL; Genazzani AA; Raffaeli W; Terrazzino S
    J Pain; 2013 Oct; 14(10):1097-106. PubMed ID: 23773341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of postoperative pain and analgesic requirements following abdominal hysterectomy: an observational study.
    Aouad MT; Kanazi GE; Malek K; Tamim H; Zahreddine L; Kaddoum RN
    J Anesth; 2016 Feb; 30(1):72-9. PubMed ID: 26499321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
    Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
    Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pain Factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement.
    Thomazeau J; Rouquette A; Martinez V; Rabuel C; Prince N; Laplanche JL; Nizard R; Bergmann JF; Perrot S; Lloret-Linares C
    Eur J Pain; 2016 May; 20(5):822-32. PubMed ID: 26517014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients.
    Matsuoka H; Arao T; Makimura C; Takeda M; Kiyota H; Tsurutani J; Fujita Y; Matsumoto K; Kimura H; Otsuka M; Koyama A; Imamura CK; Tanigawara Y; Yamanaka T; Tanaka K; Nishio K; Nakagawa K
    Oncol Rep; 2012 May; 27(5):1393-9. PubMed ID: 22293824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral morphine effectiveness in Nigerian patients with advanced cancer.
    Eyelade OR; Ajayi IO; Elumelu TN; Soyannwo OA; Akinyemi OA
    J Pain Palliat Care Pharmacother; 2012; 26(1):24-9. PubMed ID: 22448938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning.
    Olesen AE; Grønlund D; Gram M; Skorpen F; Drewes AM; Klepstad P
    BMC Res Notes; 2018 Jan; 11(1):78. PubMed ID: 29374492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.